Naapuripalstalla oli kiinnostava linkkaus Microsoftin sivulle, jossa kerrotaan retinopatian AI-seulonnasta. Videolla näkyy Remidio, Optomed Aurora ja icare DRSplus. Optomedilla näistä ainoana FDA-lupa plakkarissa.
””
It’s not just West Virginia that benefits from the IRIS software. The company has rapidly scaled operations to meet growing demand and are now processing 40,000 exams per month. This significant increase in exams has played a crucial role in reaching approximately 1.5 million patients, identifying around 150,000 at risk of severe blindness, and referring them for treatment. In 2024 alone, IRIS identified more than 60,000 patients with some form of visually threatening pathology and accomplished more than 37,000 ‘saves,’ a metric the company uses to specify the number of patients who would have gone blind without intervention.
””
Jutussa mainittu IRIS:hän ilmoitti jo aiemmin yhteistyöstä AEYE Healthin kanssa.